Navigation Links
TransCelerate BioPharma Inc. Launches Second Year Initiatives, Expands Membership and Achieves Milestones for Original Projects
Date:11/7/2013

ject, and accelerates identification and recruitment of qualified investigators, which will avoid duplication of standard site qualification and creation of investigator documentation, and thereby reducing cost and trial length.

In addition to the three new initiatives, TransCelerate will expand on two successful projects that were part of the original five initiatives:

  • Site Qualification and Training – To build upon the creation of common criteria for mutual recognition of GCP training and common forms to collect generic information about study sites, TransCelerate will provide a common framework to streamline the process for qualifying investigator sites, , and standardizing non-protocol specific forms for clinical trials. The organization will also establish criteria for training site personnel new to clinical research and trials.
  • Comparator Network – To enhance the value of the network, TransCelerate will expand on the current offerings to include products for clinical trial blinding: active & placebo, devices and bulk commercial products. The organization will also include the option of product discounts and expansion of the network in other regions of the world.

The new initiatives and extensions expand on the scope and success of the original TransCelerate initiatives, which have provided the following advances for both industry and patients:

  • A published framework and approach for Risk-Based Monitoring (RBM); launch of pilot studies for RBM across multiple member companies and therapeutic areas
  • Established criteria for

SOURCE TransCelerate BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
2. TransCelerate BioPharma Inc. Takes Steps Toward Common Clinical Trial Site Qualification & Training
3. CDISC and TransCelerate BioPharma Inc. Announce Landmark Asthma Data Standard Released for Public Review
4. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
5. PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes
6. CeNeRx BioPharma Completes $4.85 Million Financing
7. PDL BioPharma Completes Regular Quarterly Dividend Payment
8. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
9. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
10. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
11. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... BOTHELL, Wash. , Dec. 24, 2014   ... a leading developer, manufacturer and marketer of proprietary clinical ... media and precision thermal shipping products ... announced that it will hold its 2015 Annual Meeting ... Because the expected date for the Annual ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 GMO corn ... biotechnology company, Syngenta, are in the process of being ... The consolidated case is In Re: Syngenta AG MIR ... District Court for the District of Kansas. , Management ... been handed over to U.S. District Judge John W. ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 ... series is designed to introduce cutting edge ... users and partners of platform upgrades. This ... benefits; empowering users in their quest to ... tools. , According to SoundConnect’s Marketing Manager, ...
(Date:12/24/2014)... New York (PRWEB) December 23, 2014 According ... the Long Island Affiliate of ITRA Global, the national office ... but steady recovery. This is evidenced by the third ... strong stock market. Low energy costs have held inflation ... The only negative is the housing market remaining soft. , ...
Breaking Biology Technology:BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3
... Products,Corp. (OTC Bulletin Board: TKER), a manufacturer and ... today,reported that it has installed its equipment to ... new plant operated by one of the,top 10 ... test of the,application to gauge its effectiveness, during ...
... Academy ... of Dermatology, FREEPORT, N.Y., Feb. 11 ... natural receptor,OCTN- 1, are a natural part of the skin,s antioxidant defense ... The data was presented at the Poster Session at the 66th Annual,Meeting ...
... Santaris Pharma, the,Danish biopharmaceutical company developing LNA based ... Chief Executive,Officer, will be presenting an overview of ... Biotechnology Industry Organisation,s 10th Annual CEO &,Investor Conference ... 12:30 pm,US Eastern Standard Time (18:30 Central European ...
Cached Biology Technology:Tasker Products Installs Scalder Application at New Poultry Processor's Facility 2Tasker Products Installs Scalder Application at New Poultry Processor's Facility 3AGI Dermatics Clinical Data Identifies L-Ergothioneine as Part of Skin's Natural Antioxidant System 2Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008 2
(Date:12/19/2014)... 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ... team and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
(Date:12/11/2014)...  That blood pressure plays a role in human health ... medical term for high blood pressure – was first described ... cuff that,s used in measuring blood pressure was invented in ... about hypertension, its triggers and its effects. In fact, recent ... the best ways to treat it. For example, ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... impact the world,s squid species, according to a new ... and soon to be published in the journal ... commercially important, that impact may have far-reaching effects on ... "Squid are at the center of the ocean ...
... the mantle of summer pest, cicadas are perhaps the most curious. ... head, they taste good in chocolate, but as the drowning din ... them less if they emerged more often. Cicadas are unique ... So why would anyone actually want to replicate theses sounds? ...
... Laboratory of Molecular Biology in the United Kingdom have determined ... that when mutated can lead to a hereditary form of ... EMBO Journal , define the position of many of the ... alterations may affect the stability and function of the protein. ...
Cached Biology News:Acidifying oceans could spell trouble for squid 2Acidifying oceans could spell trouble for squid 3Secrets of the cicada's sound 2Secrets of the cicada's sound 3How disease mutations affect the Parkin protein 2
... Goat polyclonal to Synaptogyrin ... all tested applications). ... CIYGEGYSNAHESKQ, corresponding to Internal sequence ... Synaptogyrin 2 ...
Rabbit polyclonal to SMURF 2 ( Abpromise for all tested applications). Antigen: A KLH conjugated synthetic peptide (10-30 aa in length) at the N-term of first 50 aa of human SMURF 2. Entrez G...
Rabbit polyclonal antibody to NCOA2 [Agarose Immobilized]...
Rabbit anti Mouse ZIC2 Preservative: NaN3...
Biology Products: